Matches in Wikidata for { <http://www.wikidata.org/entity/Q91860037> ?p ?o ?g. }
- Q91860037 description "article scientifique publié en 2018" @default.
- Q91860037 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91860037 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91860037 description "scientific article published on 28 September 2018" @default.
- Q91860037 description "wetenschappelijk artikel" @default.
- Q91860037 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91860037 name "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 name "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 type Item @default.
- Q91860037 label "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 label "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 prefLabel "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 prefLabel "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 P1433 Q91860037-B8245F13-3FDD-40F9-B368-A9E54D7D6F63 @default.
- Q91860037 P1476 Q91860037-DC933D09-5EA8-4222-837D-0ADB2BC85047 @default.
- Q91860037 P2093 Q91860037-000136B7-8361-4517-A484-937074D0DE14 @default.
- Q91860037 P2093 Q91860037-05C268DA-5AFE-4970-9D9F-5364CA9352A4 @default.
- Q91860037 P2093 Q91860037-3E713F72-4075-46E3-8003-9399063E8A56 @default.
- Q91860037 P2093 Q91860037-4B8B78CC-871B-4389-A21A-8B929513A368 @default.
- Q91860037 P2093 Q91860037-5A3D8B0A-5334-4ABA-9712-D89E47E1F455 @default.
- Q91860037 P2093 Q91860037-7042246D-0C4A-43EB-B9DA-784A262941DE @default.
- Q91860037 P2093 Q91860037-84060D31-4160-48AA-8954-3BBC2BB2F82D @default.
- Q91860037 P2093 Q91860037-8CFC25E1-4875-49D2-BE6F-0EBE84E0AA04 @default.
- Q91860037 P2093 Q91860037-9A57AC5A-4121-49AF-A8BE-65E51E72BFCD @default.
- Q91860037 P2093 Q91860037-A2C453E6-0511-481E-B6B1-7B92C930F2E2 @default.
- Q91860037 P2093 Q91860037-A76AA468-423C-4A71-BEB6-AC6C51E77BDE @default.
- Q91860037 P2093 Q91860037-B524E992-963F-425E-AC69-DFF4CB2D1D22 @default.
- Q91860037 P2093 Q91860037-B54318FC-8E4D-4283-84A7-CB4224930210 @default.
- Q91860037 P2093 Q91860037-D57C4481-DE14-4632-9FC5-9D5840F8A24E @default.
- Q91860037 P2093 Q91860037-DC8B1664-EFBD-483C-9819-7ACA0202DC81 @default.
- Q91860037 P2093 Q91860037-ED382D93-85D6-4E43-9530-49A1CC370518 @default.
- Q91860037 P2093 Q91860037-ED9B8F7F-E51C-4AB2-930C-F7A744A4A82B @default.
- Q91860037 P2093 Q91860037-F38C147C-85E1-49EA-A5F5-B52C0833D947 @default.
- Q91860037 P2860 Q91860037-1B1DF6F9-2D01-48C8-A495-6F6E5C33B29F @default.
- Q91860037 P2860 Q91860037-1F562C56-274B-4948-84F1-2869E151EFC0 @default.
- Q91860037 P2860 Q91860037-2E04BE4E-86A0-447F-A66F-6AD29A5F2BFF @default.
- Q91860037 P2860 Q91860037-337353CB-9424-48BE-85F3-04D63800359E @default.
- Q91860037 P2860 Q91860037-463C83DA-1A6D-400B-91CA-C49C91C786CB @default.
- Q91860037 P2860 Q91860037-485BC6C5-D1BD-448C-B1A6-398F4952B638 @default.
- Q91860037 P2860 Q91860037-4873CCE7-4CFD-48F0-84C1-86C338745BB7 @default.
- Q91860037 P2860 Q91860037-534C79CB-B827-4261-ADEA-D7EC0862530B @default.
- Q91860037 P2860 Q91860037-5E0F5CEB-6376-4179-AE5D-35D209B4E9E5 @default.
- Q91860037 P2860 Q91860037-686EDDA8-0F27-4625-BB77-7B0AC4854DBA @default.
- Q91860037 P2860 Q91860037-8C4D6B8B-3378-49CC-A081-CD0C2B0C8401 @default.
- Q91860037 P2860 Q91860037-8F912F6B-9568-42AD-A020-8E1ED0960795 @default.
- Q91860037 P2860 Q91860037-971C7205-7109-4BC2-A18A-77C1BC03B3B6 @default.
- Q91860037 P2860 Q91860037-A88E1C20-3C3F-4031-8521-33E4B90173F3 @default.
- Q91860037 P2860 Q91860037-A9C6C101-427B-4B50-BD5B-7DA20D6CE5AA @default.
- Q91860037 P2860 Q91860037-C0822F08-75D8-4D70-8BA8-A23176FB3066 @default.
- Q91860037 P2860 Q91860037-CCC36A52-1A31-495C-8DD3-01FC18A04482 @default.
- Q91860037 P2860 Q91860037-CF428A5F-181E-4BF5-B07F-4AA030910A76 @default.
- Q91860037 P2860 Q91860037-D05E2726-49A9-4C48-B3DB-63E6C662DD79 @default.
- Q91860037 P2860 Q91860037-D53DA1BC-D3CF-4859-8C76-D3919A097AE2 @default.
- Q91860037 P2860 Q91860037-DA13F6BF-0A3F-4A2F-B152-F2E0E214B7C2 @default.
- Q91860037 P2860 Q91860037-E68EE946-AC27-4341-B06A-BC26340D0425 @default.
- Q91860037 P2860 Q91860037-E82F2298-209C-40B8-8670-37CBEA1FAD61 @default.
- Q91860037 P2860 Q91860037-FA9FE1DF-2035-4B97-9C75-3EA2B68C231A @default.
- Q91860037 P304 Q91860037-32B8AD06-467A-43CA-B589-ADA57AC5CF40 @default.
- Q91860037 P31 Q91860037-6F1F2240-B1F4-4C72-A523-BCCD5FD6181B @default.
- Q91860037 P356 Q91860037-BA693CFB-9DE7-48BA-B886-227ED059206E @default.
- Q91860037 P433 Q91860037-8DA30FB3-A2BE-463E-B3D3-78DADA3369CB @default.
- Q91860037 P478 Q91860037-13B42D8B-7F00-4224-B0F1-43FB38FC40C3 @default.
- Q91860037 P50 Q91860037-217E4ABE-0D88-4ABD-98C4-CDB01E7DA499 @default.
- Q91860037 P50 Q91860037-505ACC10-08F5-4B88-9B1E-437A1F143CAD @default.
- Q91860037 P50 Q91860037-A934E4FA-DBF8-430D-B965-596061327B43 @default.
- Q91860037 P577 Q91860037-3DBE6809-B25F-4D7A-9DC6-7F2A69D5C994 @default.
- Q91860037 P698 Q91860037-AC85C17F-5AC8-4F49-9928-379A765A4994 @default.
- Q91860037 P921 Q91860037-A8FE7B8E-58DD-4CED-9795-FA7B1E6D763D @default.
- Q91860037 P921 Q91860037-AF76AE30-C9D6-455A-A0F7-2AC01F128D2C @default.
- Q91860037 P921 Q91860037-BC11D5BA-A17D-4FB6-84A0-BA6F864F6B97 @default.
- Q91860037 P932 Q91860037-24F299F7-0CA5-46B9-B559-8F00838E2939 @default.
- Q91860037 P356 THEONCOLOGIST.2018-0290 @default.
- Q91860037 P698 30266892 @default.
- Q91860037 P1433 Q2122327 @default.
- Q91860037 P1476 "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma" @default.
- Q91860037 P2093 "Antoine F Carpentier" @default.
- Q91860037 P2093 "Chiedzo Mpofu" @default.
- Q91860037 P2093 "Dana Michaela Cernea" @default.
- Q91860037 P2093 "Enrico Franceschi" @default.
- Q91860037 P2093 "Francois Ghiringhelli" @default.
- Q91860037 P2093 "Frank Saran" @default.
- Q91860037 P2093 "François Dubois" @default.
- Q91860037 P2093 "Gaetano Finocchiaro" @default.
- Q91860037 P2093 "George Fountzilas" @default.
- Q91860037 P2093 "Giuseppe Lombardi" @default.
- Q91860037 P2093 "Hans-Joerg Urban" @default.
- Q91860037 P2093 "Josef Pichler" @default.
- Q91860037 P2093 "Martina Makrutzki" @default.
- Q91860037 P2093 "Miguel Gil-Gil" @default.
- Q91860037 P2093 "Oliver Chinot" @default.
- Q91860037 P2093 "Patrick Beauchesne" @default.
- Q91860037 P2093 "Rodica Anghel" @default.
- Q91860037 P2093 "Warren Mason" @default.
- Q91860037 P2860 Q24608005 @default.
- Q91860037 P2860 Q27860910 @default.
- Q91860037 P2860 Q29547224 @default.
- Q91860037 P2860 Q29617568 @default.
- Q91860037 P2860 Q30410163 @default.
- Q91860037 P2860 Q31148416 @default.
- Q91860037 P2860 Q33382596 @default.